Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?

Therapeutic infusions of ketamine: Do the psychoactive effects matter?

(2014) E. Dakwar et al.   DRUG AND ALCOHOL DEPENDENCE

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

(2014) Peter Gasser et al.   JOURNAL OF NERVOUS AND MENTAL DISEASE

2179 – Psychedelic drugs in psychotherapy. A revival?

(2013) V.M. Barrau-Alonso et al.   EUROPEAN PSYCHIATRY

Spirituality-Based Recovery From Drug Addiction in the Twelve-Step Fellowship of Narcotics Anonymous

(2013) Marc Galanter et al.   Journal of Addiction Medicine

Current Status of Ketamine and Related Compounds for Depression

(2013) Daniel C. Mathews et al.   JOURNAL OF CLINICAL PSYCHIATRY

Broadband Cortical Desynchronization Underlies the Human Psychedelic State

(2013) S. D. Muthukumaraswamy et al.   JOURNAL OF NEUROSCIENCE

Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on   Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations

(2013) M. Kometer et al.   JOURNAL OF NEUROSCIENCE

Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept

(2013) Carolyn I Rodriguez et al.   NEUROPSYCHOPHARMACOLOGY

Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder

(2012) Michael H. Bloch et al.   BIOLOGICAL PSYCHIATRY

Ketamine for Depression: Where Do We Go from Here?

(2012) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY

Modeling Ketamine Effects on Synaptic Plasticity During the Mismatch Negativity

(2012) A. Schmidt et al.   CEREBRAL CORTEX

The neurophenomenology of neutral hypnosis

(2012) Etzel Cardeña et al.   CORTEX

Neurophysiological Effects of Cannabinoids: Implications for Psychosis Research

(2012) Jurgen Gallinat et al.   CURRENT PHARMACEUTICAL DESIGN

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

(2012) Teri S Krebs et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Efficacy and Enlightenment: LSD Psychotherapy and the Drug Amendments of 1962

(2012) M. Oram   JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES

Canonical Microcircuits for Predictive Coding

(2012) Andre M. Bastos et al.   NEURON

Prediction of Psilocybin Response in Healthy Volunteers

(2012) Erich Studerus et al.   PLoS One

Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study

(2012) José Carlos Bouso et al.   PLoS One

Hallucinogen actions on human brain revealed

(2012) H.-M. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

(2012) R. L. Carhart-Harris et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis

(2012) Robin L. Carhart-Harris et al.   SCHIZOPHRENIA BULLETIN

Essential Role for Orbitofrontal Serotonin 1B Receptors in Obsessive-Compulsive Disorder-Like Behavior and Serotonin Reuptake Inhibitor Response in Mice

(2011) Nancy A. Shanahan et al.   BIOLOGICAL PSYCHIATRY

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

(2011) Katherine A MacLean et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

(2011) Adam L. Halberstadt et al.   NEUROPHARMACOLOGY

Mismatch Negativity Encoding of Prediction Errors Predicts S-ketamine-Induced Cognitive Impairments

(2011) André Schmidt et al.   NEUROPSYCHOPHARMACOLOGY

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

(2011) Roland R. Griffiths et al.   PSYCHOPHARMACOLOGY

Spirituality in Recovery: A Lagged Mediational Analysis of Alcoholics Anonymous’ Principal Theoretical Mechanism of Behavior Change

(2010) John F. Kelly et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

(2010) Nancy Diazgranados et al.   ARCHIVES OF GENERAL PSYCHIATRY

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

(2010) Charles S. Grob et al.   ARCHIVES OF GENERAL PSYCHIATRY

The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series

(2010) Matthias Karst et al.   CEPHALALGIA

The persistence of the subjective in neuropsychopharmacology: observations of contemporary hallucinogen research

(2010) Nicolas Langlitz   HISTORY OF THE HUMAN SCIENCES

Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder

(2010) Nancy DiazGranados et al.   JOURNAL OF CLINICAL PSYCHIATRY

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

(2010) Franz X. Vollenweider et al.   NATURE REVIEWS NEUROSCIENCE

Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)

(2010) Erich Studerus et al.   PLoS One

Hallucinogens as Medicine

(2010) Roland R. Griffiths et al.   SCIENTIFIC AMERICAN

Effects ofPsilocybe argentipeson Marble-Burying Behavior in Mice

(2009) Yoshihiro MATSUSHIMA et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Glutamate and the Neural Basis of the Subjective Effects of Ketamine

(2008) J. F. William Deakin et al.   ARCHIVES OF GENERAL PSYCHIATRY

The Pharmacology of Lysergic Acid Diethylamide: A Review

(2008) Torsten Passie et al.   CNS Neuroscience & Therapeutics

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

(2008) RR Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Serotonin research: contributions to understanding psychoses

(2008) M GEYER et al.   TRENDS IN PHARMACOLOGICAL SCIENCES